EPS8L3 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83010
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of Human EPS8L3. Peptide sequence: LFMGKLEKAQAKTSRKKKFGKKNKDQGGLTQAQYIDCFQKIKHSFNLLGR The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Description
Novus Biologicals Rabbit EPS8L3 Antibody - BSA Free (NBP2-83010) is a polyclonal antibody validated for use in WB. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for EPS8L3 Antibody - BSA Free
Western Blot: EPS8L3 Antibody [NBP2-83010]
Western Blot: EPS8L3 Antibody [NBP2-83010] - Host: Rabbit. Target Name: EPS8L3. Sample Type: NCI-H226 Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for EPS8L3 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: EPS8L3
Alternate Names
epidermal growth factor receptor kinase substrate 8-like protein 3, Epidermal growth factor receptor pathway substrate 8-related protein 3, EPS8-like 3, EPS8-like protein 3, EPS8R3, EPS8-related protein 3, FLJ21522, MGC16817
Gene Symbol
EPS8L3
Additional EPS8L3 Products
Product Specific Notices for EPS8L3 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...